Evidence map›Paper›PMID 34530854›Full record

ArticleJournal of neuroinflammation2021

Autophagy protein NRBF2 attenuates endoplasmic reticulum stress-associated neuroinflammation and oxidative stress via promoting autophagosome maturation by interacting with Rab7 after SAH.

Hanhai Zeng, Huaijun Chen, Min Li, Jianfeng Zhuang, Yucong Peng, Hang Zhou, Chaoran Xu, Qian Yu, Xiongjie Fu, Shenglong Cao and 3 more

Open access · goldAbstract read
In one paragraph

Article in Journal of neuroinflammation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
8.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 66 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Shikonin attenuates blood-brain barrier injury and oxidative stress in rats with subarachnoid hemorrhage by activating Sirt1/Nrf2/HO-1 signaling.The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 2025
    Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Advances in the study of autophagy in breast cancer.Breast cancer (Tokyo, Japan) · 2024
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Hanhai Zeng *Department of Neurological Surgery, The Second Affiliated Hospital of Zhejiang University School of Medicine, Jiefang Road 88th, Hangzhou, 310009, Zhejiang Province, China.
Huaijun Chen *Department of Neurological Surgery, The Second Affiliated Hospital of Zhejiang University School of Medicine, Jiefang Road 88th, Hangzhou, 310009, Zhejiang Province, China.
Min Li *Neurosurgical Intensive Care Unit, The Second Affiliated Hospital of Zhejiang University School of Medicine, Jiefang Road 88th, Hangzhou, 310009, Zhejiang Province, China.
Jianfeng ZhuangDepartment of Neurological Surgery, The Second Affiliated Hospital of Zhejiang University School of Medicine, Jiefang Road 88th, Hangzhou, 310009, Zhejiang Province, China.
Yucong PengDepartment of Neurological Surgery, The Second Affiliated Hospital of Zhejiang University School of Medicine, Jiefang Road 88th, Hangzhou, 310009, Zhejiang Province, China.
Hang ZhouDepartment of Neurological Surgery, The Second Affiliated Hospital of Zhejiang University School of Medicine, Jiefang Road 88th, Hangzhou, 310009, Zhejiang Province, China.
Chaoran XuDepartment of Neurological Surgery, The Second Affiliated Hospital of Zhejiang University School of Medicine, Jiefang Road 88th, Hangzhou, 310009, Zhejiang Province, China.
Qian YuDepartment of Neurological Surgery, The Second Affiliated Hospital of Zhejiang University School of Medicine, Jiefang Road 88th, Hangzhou, 310009, Zhejiang Province, China.
Xiongjie FuDepartment of Neurological Surgery, The Second Affiliated Hospital of Zhejiang University School of Medicine, Jiefang Road 88th, Hangzhou, 310009, Zhejiang Province, China.
Shenglong CaoDepartment of Neurological Surgery, The Second Affiliated Hospital of Zhejiang University School of Medicine, Jiefang Road 88th, Hangzhou, 310009, Zhejiang Province, China.
Jing CaiNeurosurgical Intensive Care Unit, The Second Affiliated Hospital of Zhejiang University School of Medicine, Jiefang Road 88th, Hangzhou, 310009, Zhejiang Province, China.
Feng YanDepartment of Neurological Surgery, The Second Affiliated Hospital of Zhejiang University School of Medicine, Jiefang Road 88th, Hangzhou, 310009, Zhejiang Province, China. fengyanzju@zju.edu.cn.
Gao ChenDepartment of Neurological Surgery, The Second Affiliated Hospital of Zhejiang University School of Medicine, Jiefang Road 88th, Hangzhou, 310009, Zhejiang Province, China. d-chengao@zju.edu.cn.ORCID http://orcid.org/0000-0003-1085-0028
Second Affiliated Hospital of Zhejiang University · CN

Funding

National Key R&D program of China 2018YFC1312600, 2018YFC1312603National Natural Science Foundation of China No.81571106, 81771246, 81971099, 81870908TCM Key Discipline of Zhejiang province 2017-XK-A39TCM Science and Technology Plan of Zhejiang province 2017ZZ013
6 · The paper itself

Abstract

backgroundNeuroinflammation and oxidative stress plays an important role in the pathogenesis of early brain injury (EBI) after subarachnoid hemorrhage (SAH). This study is the first to show that activation of autophagy protein nuclear receptor binding factor 2 (NRBF2) could reduce endoplasmic reticulum stress (ERS)-associated inflammation and oxidative stress after SAH.

methodsMale C57BL/6J mice were subjected to endovascular perforation to establish a model of SAH. NRBF2 overexpression adeno-associated virus (AAV), NRBF2 small interfering RNAs (siRNA), lysosomal inhibitor-chloroquine (CQ), and late endosome GTPase Rab7 receptor antagonist-CID1067700 (CID) were used to investigate the role of NRBF2 in EBI after SAH. Neurological tests, brain water content, western blotting and immunofluorescence staining were evaluated.

resultsOur study found that the level of NRBF2 was increased after SAH and peaked at 24 h after SAH. In addition, we found that the overexpression of NRBF2 significantly improved neurobehavioral scores and reduced ERS, oxidative stress, and neuroinflammation in SAH, whereas the inhibition of NRBF2 exacerbated these phenotypes. In terms of mechanism, NRBF2 overexpression significantly promoted autophagosome maturation, with the downregulation of CHOP, Romo-1, TXNIP, NLRP3, TNF-α, and IL-1β expression through interaction with Rab7. The protective effect of NRBF2 on ERS-associated neuroinflammation and oxidative stress after SAH was eliminated by treatment with CQ. Meanwhile, it was also reversed by intraperitoneal injection of CID. Moreover, the MIT domain of NRBF2 was identified as a critical binding site that interacts with Rab7 and thereby promotes autophagosome maturation.

conclusionOur data provide evidence that the autophagy protein NRBF2 has a protective effect on endoplasmic reticulum stress-associated neuroinflammation and oxidative stress by promoting autophagosome maturation through interactions with Rab7 after SAH.

Indexed as

AnimalsAutophagosomesAutophagyAutophagy-Related ProteinsEndoplasmic Reticulum StressMaleMiceMice, Inbred C57BLNeuroinflammatory DiseasesOxidative Stressrab7 GTP-Binding ProteinsSubarachnoid HemorrhageTrans-ActivatorsAutophagy-Related ProteinsNrbf2 protein, mouserab7 GTP-Binding Proteinsrab7 GTP-binding proteins, mouseTrans-ActivatorsAutophagy maturationEndoplasmic reticulum stressNeuroinflammationNRBF2Oxidative stressRab7Subarachnoid hemorrhage

Identifiers

PMID34530854
PMCPMC8447596
OpenAlexW3200405206

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.